Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor B Lovejoy, A Cleasby, AM Hassell, K Longley, MA Luther, D Weigl, ... Science 263 (5145), 375-377, 1994 | 426 | 1994 |
Comprehensive characterization of the published kinase inhibitor set JM Elkins, V Fedele, M Szklarz, KR Abdul Azeez, E Salah, J Mikolajczyk, ... Nature biotechnology 34 (1), 95-103, 2016 | 348 | 2016 |
New compound sets identified from high throughput phenotypic screening against three kinetoplastid parasites: an open resource I Pena, M Pilar Manzano, J Cantizani, A Kessler, J Alonso-Padilla, ... Scientific reports 5 (1), 8771, 2015 | 278 | 2015 |
Discovery of I-BRD9, a selective cell active chemical probe for bromodomain containing protein 9 inhibition NH Theodoulou, P Bamborough, AJ Bannister, I Becher, RA Bit, KH Che, ... Journal of medicinal chemistry 59 (4), 1425-1439, 2016 | 238 | 2016 |
Quantitative, wide-spectrum kinase profiling in live cells for assessing the effect of cellular ATP on target engagement JD Vasta, CR Corona, J Wilkinson, CA Zimprich, JR Hartnett, MR Ingold, ... Cell chemical biology 25 (2), 206-214. e11, 2018 | 229 | 2018 |
Solid‐supported reagents in organic synthesis DH Drewry, DM Coe, S Poon Medicinal research reviews 19 (2), 97-148, 1999 | 216 | 1999 |
Assessment of chemical coverage of kinome space and its implications for kinase drug discovery P Bamborough, D Drewry, G Harper, GK Smith, K Schneider Journal of medicinal chemistry 51 (24), 7898-7914, 2008 | 206 | 2008 |
A public-private partnership to unlock the untargeted kinome S Knapp, P Arruda, J Blagg, S Burley, DH Drewry, A Edwards, D Fabbro, ... Nature chemical biology 9 (1), 3-6, 2013 | 173 | 2013 |
Enhancements of screening collections to address areas of unmet medical need: an industry perspective DH Drewry, R Macarron Current opinion in chemical biology 14 (3), 289-298, 2010 | 167 | 2010 |
Discovery and characterization of GSK2801, a selective chemical probe for the bromodomains BAZ2A and BAZ2B P Chen, A Chaikuad, P Bamborough, M Bantscheff, C Bountra, C Chung, ... Journal of medicinal chemistry 59 (4), 1410-1424, 2016 | 164 | 2016 |
Progress towards a public chemogenomic set for protein kinases and a call for contributions DH Drewry, CI Wells, DM Andrews, R Angell, H Al-Ali, AD Axtman, ... PloS one 12 (8), e0181585, 2017 | 160 | 2017 |
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase ND Adams, JL Adams, JL Burgess, AM Chaudhari, RA Copeland, ... Journal of medicinal chemistry 53 (10), 3973-4001, 2010 | 132 | 2010 |
Seeding collaborations to advance kinase science with the GSK Published Kinase Inhibitor Set (PKIS) D H Drewry, T M Willson, W J Zuercher Current topics in medicinal chemistry 14 (3), 340-342, 2014 | 128 | 2014 |
Donated chemical probes for open science S Müller, S Ackloo, CH Arrowsmith, M Bauser, JL Baryza, J Blagg, ... elife 7, e34311, 2018 | 102 | 2018 |
Plasmodium Kinases As Targets For New-Generation Antimalarials IS Lucet, A Tobin, D Drewry, AF Wilks, C Doerig Future medicinal chemistry 4 (18), 2295-2310, 2012 | 102 | 2012 |
Solid-phase synthesis of trisubstituted guanidines DH Drewry, SW Gerritz, JA Linn Tetrahedron letters 38 (19), 3377-3380, 1997 | 97 | 1997 |
CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer L Racioppi, ER Nelson, W Huang, D Mukherjee, SA Lawrence, W Lento, ... Nature Communications 10 (1), 2450, 2019 | 94 | 2019 |
Quantifying CDK inhibitor selectivity in live cells CI Wells, JD Vasta, CR Corona, J Wilkinson, CA Zimprich, MR Ingold, ... Nature communications 11 (1), 2743, 2020 | 89 | 2020 |
The kinase chemogenomic set (KCGS): an open science resource for kinase vulnerability identification CI Wells, H Al-Ali, DM Andrews, CRM Asquith, AD Axtman, I Dikic, ... International journal of molecular sciences 22 (2), 566, 2021 | 88 | 2021 |
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen S Scheipl, M Barnard, L Cottone, M Jorgensen, DH Drewry, WJ Zuercher, ... The Journal of pathology 239 (3), 320-334, 2016 | 85 | 2016 |